Evidence map›Paper›PMID 32709653›Full record

ArticleBMJ open2020

SEPSIS project: a protocol for studying biomarkers of neonatal sepsis and immune responses of infants in a malaria-endemic region.

Nadine Fievet, Sem Ezinmegnon, Gino Agbota, Darius Sossou, Rodolphe Ladekpo, Komi Gbedande, Valerie Briand, Gilles Cottrell, Laurence Vachot, Javier Yugueros Marcos and 13 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03780712 (Neonatal Immune Dysfunction Associated to the Risk of Newborn Sepsis in Benin), which is not on this map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03780712 completednot on this map

Neonatal Immune Dysfunction Associated to the Risk of Newborn Sepsis in Benin

TypeobservationalSponsorBioMérieuxRan2016 to 2018Enrolled585ConditionsSepsis Newborn, Malaria, Immune ResponsesArmsNon applicable
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Procalcitonin as a Candidate Biomarker for Malarial Infection and Severe Malaria: A Meta-Analysis.International journal of environmental research and public health · 2022
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Observational
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 9 institutions in 2 countries.

Nadine FievetInstitut de Recherche pour le Développement (IRD), Mère et enfant face aux infections tropicales (UMR216), Paris, France.
Sem EzinmegnonDepartment of Microbiology, Institut de Biologie Integrative de la Cellule, Gif-sur-Yvette, France.
Gino AgbotaUMR216-MERIT, French National Research Institute for Sustainable Development (IRD), Université Paris Descartes, Paris, France.
Darius SossouInstitut de Recherche Clinique du Bénin, Calavi, Benin.
Rodolphe LadekpoInstitut de Recherche Clinique du Bénin, Calavi, Benin.
Komi GbedandeInstitut de Recherche Clinique du Benin, Cotonou, Benin.
Valerie BriandInstitut de Recherche pour le Développement (IRD), Mère et enfant face aux infections tropicales (UMR216), Paris, France.
Gilles CottrellUMR216, Institut de Recherche pour le Développement, Cotonou, Benin.
Laurence VachotMedical Diagnostic Discovery Department (MD3), bioMerieux SA, Marcy l'Etoile, Rhône-Alpes, France.
Javier Yugueros MarcosMedical Diagnostic Discovery Department (MD3), bioMerieux SA, Marcy l'Etoile, Rhône-Alpes, France.
Alexandre PachotEA 7426 Pathophysiology of Injury-Induced Immunosuppression, bioMerieux, LYON cedex 03, France.
Julien TextorisEA 7426 Pathophysiology of Injury-Induced Immunosuppression, bioMerieux, LYON cedex 03, France.ORCID 0000-0002-3821-9337
Sophie BleinMedical Diagnostic Discovery Department (MD3), bioMerieux SA, Marcy l'Etoile, Rhône-Alpes, France.
Ulrik Lausten-ThomsenPediatric Intensive Care, Hopitaux Universitaires Paris-Sud, Le Kremlin-Bicetre, France.
Achille MassougbodjiFaculté des Sciences de la Santé (FSS), Cotonou, Benin.
Lehila BagnanInstitut de Recherche Clinique du Bénin, Calavi, Benin.
Nicole TchiakpeInstitut de Recherche Clinique du Bénin, Calavi, Benin.
Marceline d'AlmeidaDepartment of Paediatric, National University Hospital Center (CNHU), Cotonou, Benin.
Jules AlaoCHU-MEL Hospital, Cotonou, Benin.
Ida Dossou-DagbaCalavi Hospital, Calavi, Benin.
Pierre TissieresDepartment of Microbiology, Institut de Biologie Integrative de la Cellule, Gif-sur-Yvette, France pierre.tissieres@aphp.fr.ORCID 0000-0001-5423-5532
SEPSIS study group collaborators
SEPSIS study group
bioMérieux (France) · FRCentre National Hospitalier et Universitaire Hubert Koutoukou MAGA · BJDélégation Paris 5 · FRInstitut de Biologie Intégrative de la Cellule · FRHôpitaux Universitaires Paris-Ouest · FRHospices Civils de Lyon · FRMère et enfant en milieu tropical : pathogènes, système de santé et transition épidémiologique · FRMinistre de la Santé · BJUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionNeonatal sepsis outreaches all causes of neonatal mortality worldwide and remains a major societal burden in low and middle income countries. In addition to limited resources, endemic morbidities, such as malaria and prematurity, predispose neonates and infants to invasive infection by altering neonatal immune response to pathogens. Nevertheless, thoughtful epidemiological, diagnostic and immunological evaluation of neonatal sepsis and the impact of gestational malaria have never been performed. METHODS AND ANALYSIS: A prospective longitudinal multicentre follow-up of 580 infants from birth to 3 months of age in urban and suburban Benin will be performed. At delivery, and every other week, all children will be examined and clinically evaluated for occurrence of sepsis. At delivery, cord blood systematic analysis of selected plasma and transcriptomic biomarkers (procalcitonin, interleukin (IL)-6, IL-10, IP10, ETHICS AND DISSEMINATION: Ethical approval has been obtained from the Comité d'Ethique de la Recherche - Institut des Sciences Biomédicales Appliquées (CER-ISBA 85 - 5 April 2016, extended on 3 February 2017). Results will be disseminated through international presentations at scientific meetings and publications in peer-reviewed journals. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov registration number: NCT03780712.

Indexed as

MalariaNeonatal SepsisSepsisAfrica, NorthernBeninBiomarkersChildHumansImmunityInfantInfant, NewbornLeukocytes, MononuclearProspective StudiesBiomarkersimmunologyneonatal intensive & critical careneonatologypaediatric infectious disease & immunisation

Identifiers

PMID32709653
PMCPMC7380952
OpenAlexW3044874961

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.